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Cathepsins are a group of cystein proteinases that are involved in various aspects of extracellular matrix
turnover. The collagenolytic activity of cathepsin K plays a pivotal role in bone resorption and lung matrix
homeostasis, but so far has not been described in skin. To study the role of cathepsin K in the turnover of the
cutaneous extracellular matrix, we studied the expression of cathepsin K in human skin and in cultured primary
neonatal skin fibroblasts. Normal skin exhibited only low levels or no expression of cathepsin K. In contrast,
dermal fibroblasts in surgical scars showed strong cytoplasmic cathepsin K expression. Cathepsin K expression
was most prominent in young scars and declined with time. Cultured neonatal primary fibroblasts showed
strong cathepsin K staining in the perinuclear endosomal compartment, consistent with intracellular
degradation of internalized collagen in lysosomes. Cathepsin K was also found to be strongly expressed in
keloids and dermatofibromas, but not in sclerotic areas of morphea. Our data suggest that cathepsin K may play
an important role in the homeostasis of the dermal extracellular matrix and the dynamic equilibrium between
matrix synthesis and proteolytic degradation, by counteracting deposition of matrix proteins during scar
formation with its matrix-degrading activity.
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INTRODUCTION
Cathepsins are a group of papain-cystein proteases with
collagenolytic and elastinolytic activities that are involved in
various aspects of extracellular matrix turnover (Everts et al.,
1996; Chapman et al., 1997). Several cathepsins, including
cathepsins L and G, have been described to be expressed in
skin or skin-derived cells (Breuckmann et al., 2002; Tobin
et al., 2002; Potts et al., 2004; Zhao et al., 2005, and others),
but so far not cathepsin K.
Cathepsin K is well established to play a pivotal role in
bone resorption (Drake et al., 1996; Garnero et al., 1996;
Yamaza et al., 1998; Xia et al., 1999; Goto et al., 2003). Its
collagenolytic properties are unique in that it cleaves type I
and type III collagen at the end and at multiple sites within
the native triple helix. In addition, it is the most potent human
elastase yet described. It is a lysosomal enzyme that has an
acidic pH optimum of 5.5 and limited stability at neutral pH
(Bossard et al., 1996). It is synthesized in mature osteoclasts
as an inactive proenzyme. It is located in lysosomes, cleaved
by autoproteolysis to produce the active form, and then
secreted into the bone resorption lacunae (McQueney et al.,
1997; Dodds et al., 2001; Rieman et al., 2001). It contributes
to bone resorption by degrading collagen fibrils in the acidic
bone resorption zones and by degrading fragmented colla-
gens fibrils in endolysosomes after phagocytosis. The role of
cathepsin K in bone resorption is further underlined by
findings that cathepsin K mutations lead to pycnodysostosis,
an autosomal-recessive osteochondrodysplasia characterized
by defective bone matrix degradation (Gelb et al., 1996), and
that cathepsin K-knockout mice develop osteopetrosis
(abnormally dense bone) owing to defective bone resorption
(Saftig et al., 1998).
Cathepsin K-knockout mice are also more prone to
develop bleomycin-induced lung fibrosis (Bu¨hling et al.,
2004), indicating that cathepsin K also plays an important
role in the homeostasis of the extracellular matrix in the lung.
This is further supported by reports that in a mouse model of
silica-induced lung fibrosis cathepsin K is strongly upregu-
lated in fibroblasts of fibrotic lungs (van den Bruˆle et al.,
2005).
In addition, cathepsin K has also been shown to be
expressed in synovial fibroblasts from joints of patients with
rheumatoid arthritis, where it is thought to contribute to
cartilage and subcortical bone degradation (Hou et al., 2001).
In order to study a possible role of cathepsin K in the
homeostasis of the cutaneous extracellular matrix, we
studied expression of cathepsin K in normal skin, surgical
scars of various age (time since surgical procedure ranging
from 1 month to 3 years), keloids, dermatofibromas,
sclerotic plaques of morphea, and in primary human neonatal
fibroblasts cultured on glass slides using immune-histo-
chemistry. In addition, Western blot analysis was used to
evaluate cathepsin K expression in cultured primary dermal
fibroblasts.
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RESULTS
Western blot analysis and immune-histochemistry clearly
demonstrate expression of cathepsin K in cultured human
fibroblasts (Figure 1). Comparison of exponentially growing
cells with cells grown to confluence shows stronger cathepsin
K expression in the confluent cells in Western blots, affecting
both the procathepsin K and the active cathepsin K (Figure
1a). Within cells, cathepsin K staining is found in the
perinuclear endosomal compartment (Figure 1b).
Within apparent normal skin, peripheral to the scar, there
is only weak or no expression of cathepsin K in dermal
fibroblasts (Figure 2). In stark contrast to the normal skin,
dermal fibroblasts of surgical scars show strong cathepsin K
staining (Figure 2). The most prominent staining is observed
in young scars, and a less intensive staining in older scars, at
least up to 18 months after the surgical procedure. A 3-year-
old scar did not show any cathepsin K expression (data not
shown). Epidermal keratinocytes overlying some, but not all
young surgical scars, also demonstrated intracellular cathe-
psin K expression (Figure 2). Such staining of epidermal
keratinocytes was not observed in any area outside the
surgical scars in the scar specimens.
Strong cytoplasmic cathepsin K expression was also
observed in keloids and a dermatofibroma (Figure 3). In
contrast, no cathepsin K expression was observed in the
sclerotic areas of morphea (Figure 4). When a particular
sample shows no staining at all, a false-negative staining
cannot be ruled out completely, even if other samples that
were processed in parallel do show positive staining.
However, in some of the morphea specimens, a weak
staining of fibroblasts was seen focally in the normal dermis
overlying the fibrotic areas (Figure 4b). This serves as a
positive internal control for the otherwise negative cathepsin
K staining in this sample, as it demonstrates adequate staining
technique.
DISCUSSION
The homeostasis of the extracellular matrix depends on a
dynamic equilibrium between synthesis and degradation of
extracellular matrix proteins. It is tightly controlled under
physiologic conditions, and its disruption may lead to either
fibrosing or atrophic conditions. During wound healing and
scar formation, this equilibrium is initially shifted to a
profibrotic state in order to accommodate the required
synthesis of new extracellular matrix proteins. This shift,
however, also requires counteraction for remodeling of the
scar and for rebalancing the equilibrium to a normal steady
state after completion of wound healing.
Our data introduce cathepsin K as a new antifibrotic
player in the homeostasis of extracellular matrix proteins in
the skin. Although in the steady state of normal skin,
cathepsin K is not or only weakly expressed, its proteolytic
activities appear to be required for rebalancing the homeo-
stasis during scar formation, as it is highly expressed in
dermal fibroblasts of scars. Presumably, this counteracts
excessive matrix deposition, facilitates remodeling, and
prevents formation of hypertrophic scars. This model
corresponds to the suggested roles of cathepsin K in
fibroblasts of other organs: in lung fibroblasts, where it
counteracts damage-induced fibrosis (Bu¨hling et al., 2004;
van den Bruˆle et al., 2005); in synovial fibroblasts, where it
mediates cartilage and bone resorption in pathologic states
(Hou et al., 2001); and in fibroblasts of ligaments, where it is
upregulated after subfailure (sprain) injury.
Consistent with its well-known character of a lysosomal
protein, our data show that cathepsin K is localized in the
perinuclear endosomal compartment also in dermal fibro-
blasts. Fibroblasts are known to internalize extracellular
collagen after binding of collagen to collagen receptors
(e.g., a2b1 integrins) (Lee et al., 1996), and inhibition of
cathepsin K has been shown to result in intralysosomal
collagen accumulation in synovial fibroblasts (Hou et al.,
2001). As cathepsin K is active only at low pH and
normally confined to the lysosomal network (Bossard
et al., 1996; McQueney et al., 1997; Dodds et al., 2001;
Rieman et al., 2001), we assume that in skin fibroblasts
its activity is also limited to lysosomes and that it cleaves
dermal collagen after binding of collagen to the fibroblasts’
collagen receptors and internalization of collagen through
phagocytosis.
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Figure 1. Expression of cathepsin K in surgical scars. Cathepsin K is
expressed in cultured human neonatal dermal fibroblasts. (a) Western blot
and (b) immune-histochemistry of cells grown on glass slides, showing
localization of cathepsin K to the perinuclear endosomal compartment.
Bar¼20 mm.
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In bone resorption, osteoclasts generate an acidic micro-
environment in the bone resorption lacunae that allows
secreted active cathepsin K to exert its proteolytic activity
also in the extracellular space. Little is known about
extracellular functions of cathepsin K in other cell types.
Monocyte-derived macrophages have been shown to be
capable to secrete cathepsin K, to acidify the pericellular
milieu, and thus to maintain the enzyme in its active form
(Punturieri et al., 2000). It is perceivable that in acute wounds
with their acidic milieu created, for example, by inflamma-
tory neutrophil infiltrates, secreted cathepsin K could be
active in the extracellular space. In the scars that we
examined, however, in the absence of an inflammatory
infiltrate, it is highly unlikely that the extracellular milieu is
sufficiently acidic to allow cathepsin K to be active in the
extracellular space. We therefore believe that the role of
cathepsin K in the remodeling of cutaneous scars is primarily
mediated through the above-mentioned intracellular action.
This would be in contrast to the known role of secreted
metalloproteinases in wound healing and their activity in the
extracellular space (Everts et al., 1996; Mott and Werb,
2004).
Scar, overview
1 month
2.5 months
4 months
15 months
Scar, close-up Periphery of scar, close-upage of scar:
Figure 2. Expression of cathepsin K in surgical scars. Cathepsin K expression is more prominent in younger scars (1–2.5 months after surgical procedure) than in
older scars (4–15 months after surgical procedure). Shown is a representative selection of the 43 scars examined. Bars¼ 100mm for each column of panels.
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Our finding that older scars demonstrate lower cathepsin K
expression than younger scars could be related to different
proliferative activities of dermal fibroblasts in young and
older scars. However, our finding that proliferating neonatal
fibroblasts express less cathepsin K than fibroblasts grown to
confluence makes that explanation unlikely. Rather, it
appears that cathepsin K expression is related to a higher
cell density. This in turn suggests an autocrine mechanism
involving a cathepsin K-inducing mediator. A cell density-
dependent cathepsin K expression might also explain why the
fibroblasts in the cell-rich keloids and in dermatofibromas
strongly express cathepsin K, whereas the few scattered
fibroblasts in the sclerotic areas of morphea do not. There-
fore, we do not want to affirm that the excessive deposition of
extracellular matrix proteins in morphea is related to an
insufficient cathepsin K expression of dermal fibroblasts after
skin trauma, although this remains a possibility.
Cathepsin K expression by keratinocytes was limited to the
epidermis overlying some young scars. The epidermis over-
lying young scars is most commonly flat, as rete ridges have
not yet been formed. As keratinocyte migration is known to
be greatly dependent on contact with the various extra-
cellular matrix proteins (O’Toole, 2001), it is perceivable that
the cathepsin K expression of keratinocytes in these areas,
possibly in concert with keratinocyte-derived matrix metallo-
proteinases, enables keratinocytes to grow into the dermis for
the formation of rete ridges.
Any attempts to use the antifibrotic properties of cathepsin
K for treatment of skin disease would need to take into
account that its activity is limited to acidic milieus. An
induction of cathepsin K expression might be an avenue to
use its properties for treatment of fibrotic skin diseases or for
avoiding overly fibrotic scaring. Based on our data, this
would be particularly promising in fibroblast-rich fibrosing
conditions that do not express sufficient amounts of cathepsin
K and less promising in skin fibroses that are characterized by
low cellularity, such as morphea.
Inhibition of cathepsin K has been suggested to be a very
promising strategy for the treatment of osteoporosis or
rheumatoid arthritis (Chapman et al., 1997; Grabowskal
et al., 2005; Yasuda et al., 2005). Such an inhibition of
cathepsin, however, has been warned to possibly increase the
risk of lung fibrosis (Bu¨hling et al., 2004). Based on our data,
we would like to extend that warning to the skin, suggesting
that systemic inhibition of cathepsin K might make skin more
prone to excessive matrix protein deposition in response to
trauma.
MATERIALS AND METHODS
Primary human fibroblasts were derived from dermal explants of
neonatal foreskin as described previously (Stanulis-Praeger and
Gilchrest, 1989) and cultured in DMEM (Gibco/BRL, Rockland, MA)
supplemented with 10% calf serum at 371C and 5% CO2. For
cathepsin K immunostaining, cells were grown on glass slides. For
Western blot analysis, cells were grown in regular tissue culture
dishes and protein was harvested either from exponentially growing
cells or from cells that were growth arrested by confluence for
4 days.
Western blot analysis was performed according to standard
procedures using a 10% polyacrylamide gel, a rabbit polyclonal
cathepsin K antibody (ABcam, Cambridge, MA) at a dilution of 1:200
that detects both procathepsin K and the active cathepsin K, an
enhanced chemiluminescent rabbit IgG horseradish peroxidase-
linked secondary whole antibody (Amersham Biosciences; Piscat-
away, NJ) at a dilution of 1:2,000, and the Western lightning
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Figure 3. Strong expression of cathepsin K in a keloid and a dermatofibroma.
Panels a and c show a keloid, panels b and d a dermatofibroma. All three
keloids examined showed a similar strong cathepsin K expression.
Bars¼ 100 mm.
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Morphea
Figure 4. No expression of cathepsin K in the sclerotic areas of morphea.
Overview in a, close-up of sclerotic areas in c and d, whereas fibroblasts
in the overlying normal dermis (b) show weak expression of cathepsin
K (positive internal control). None of the five specimens of morphea examined
showed any cathepsin K reactivity in the sclerotic areas. Bars¼ 100mm.
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chemiluminescence reagent (Perkin-Elmer, Wellesley, MA) for
autoradiographic detection. For loading control, actin was detected
using a goat polyclonal actin horseradish peroxidase-conjugated
antibody (Santa Cruz Biotechnology; Santa Cruz, CA) at a dilution of
1:1,000.
Formalin-fixed paraffin-embedded sections of surgical scars
(n¼ 43) of various age (time since surgery ranging from 1 month
to 3 years), keloids (n¼ 3), sclerotic plaques of morphea (n¼ 5),
and a dermatofibroma, and of fixed fibroblasts grown on glass
slides were stained for cathepsin K using a monoclonal anti-
cathepsin K antibody (Novocastra, Newcastle upon Tyne, UK) at a
dilution of 1:40, for 32 minutes on an automated immune-
histochemistry system (Ventana Benchmark LT; Ventana Medical
Systems, Tucson, AZ), using the Enhance V-Red detection (alkaline
phosphatase red) kit (Ventana Medical Systems, Tucson, AZ) with a
biotinylated secondary antibody and following the manufacturer’s
protocol. The slides were treated with ChemMate blocking solution
A and B (Ventana Biomedical Systems, Tucson, AZ), counterstaining
with hematoxylin and postcounter staining with blueing reagent
(Ventana Medical Systems, Tucson, AZ). The age of tissue donors
ranged from 27 to 60 years. The study was performed with
institutional approval and followed the Declaration of Helsinki
Principles. It was exempt from patient consent, as no patient
identifiers were used.
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